- Home
- ABSI vs USNA Comparison
ABSI vs USNA Comparison
Compare ABSI & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABSI | USNA |
|---|---|---|
| Founded | 2011 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.9M | 317.0M |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ABSI | USNA |
|---|---|---|
| Price | $4.98 | $18.55 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.96 | N/A |
| AVG Volume (30 Days) | ★ 4.5M | 92.0K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.64 | N/A |
| EPS | N/A | ★ 0.58 |
| Revenue | $4,534,000.00 | ★ $1,060,902,000.00 |
| Revenue This Year | $215.96 | $3.90 |
| Revenue Next Year | $319.10 | $6.21 |
| P/E Ratio | ★ N/A | $32.14 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.24 | $16.60 |
| 52 Week High | $5.23 | $38.32 |
Technical Indicators
Market Signals| Indicator | ABSI | USNA |
|---|---|---|
| Relative Strength Index (RSI) | 76.96 | 48.46 |
| Support Level | $2.52 | $16.70 |
| Resistance Level | $5.23 | $21.21 |
| Average True Range (ATR) | 0.36 | 0.66 |
| MACD | 0.15 | -0.02 |
| Stochastic Oscillator | 93.40 | 28.88 |
Price Performance
Historical ComparisonAbout ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About USNA USANA Health Sciences Inc.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.